Natus is a provider of healthcare products and services used for the screening, detection, treatment, monitoring and tracking of common medical ailments in neurological dysfunction, epilepsy, sleep disorders, newborn care, hearing impairment and balance and mobility disorders.
Natus Announces $20 Million Share Repurchase Program. Natus Receives 510(k) FDA Clearance for the Quantum High Channel Count Amplifier. Natus Medical Announces Entry Into Neurodiagnostic Services Market. Natus Enters Streaming Newborn Video Market.
|Key Personnel: James Hawkins, president & CEO; Jonathan Kennedy, SVP & CFO; Austin Noll III, VP & GM, neurology; Kenneth Traverso, VP & GM, newborn care; Dr. Christopher Chung, VP, medical affairs, quality & regulatory;|
6701 KOLL CENTER PARKWAY